Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03480373 · ClinicalTrials.gov registry record
Electronic Cigarette Use During Pregnancy
A clinical trial of Cigarette Smoking-Related Carcinoma, sponsored by UConn Health.
- Completed
- Registry status
- 182
- Enrollment target
- 6
- Study locations
NCT03480373: Completed study of Cigarette Smoking-Related Carcinoma, sponsored by UConn Health.
NCT03480373 is a study of Cigarette Smoking-Related Carcinoma that has completed, run by UConn Health. The registered enrollment target is 182 participants, below the 459-participant average among 21 other Cigarette Smoking-Related Carcinoma trials with a reported enrollment target (60% lower). The trial reports 6 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03480373, a study of Cigarette Smoking-Related Carcinoma, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- 182 participants
- Enrollment target
- 6
- Study locations
Study Summary
Aim 1: To compare the overall toxicant exposure in pregnant women who use electronic cigarettes (e-cigs, vapor, e-liquid, e-juice, vape, vaping devices) compared to women who smoke conventional cigarettes. Aim 2. To compare toxicant exposure and birth outcomes among infants born to pregnant women who use e-cigs compared to women who smoke conventional cigarettes. Aim 3. To explore potential mechanisms by which e-cigs could influence birth weight.
Primary Outcome
The overall toxicant exposure will be measured at each trimester and adjusted for potential confounding covariates. A multivariate analysis of variance (MANOVA) with repeated measures will be used to evaluate the pregnant women who use electronic cigarettes compared to women who smoke conventional cigarettes at each trimester.
Conditions Studied
Study Locations (6)
Colorado
- University of Colorado - Denver
- Denver Health Medical Center - Denver
Connecticut
- UCONN Health - Farmington
- Women's Ambulatory Health Services at Hartford Hospital - Hartford
Massachusetts
- Baystate Medical Center - Springfield
Tennessee
- East Tennessee State University - Johnson City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2018-06-18 |
| Est. Completion | 2023-08-30 |
What the finished NCT03480373 record still lists
NCT03480373 is an observational study that tracks outcomes without assigning an intervention. The registered 182 participants enrollment target is mid-sized for trials with a published cap, below the 459-participant average among 21 other Cigarette Smoking-Related Carcinoma trials with a reported enrollment target (60% lower).
The record links to 1 condition, with Cigarette Smoking-Related Carcinoma appearing as the primary indexed condition, and to 0 interventions.
NCT03480373 lists 6 locations in 4 states (Colorado, Connecticut, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT03480373 about?
NCT03480373 is a clinical study titled "Electronic Cigarette Use During Pregnancy". Aim 1: To compare the overall toxicant exposure in pregnant women who use electronic cigarettes (e-cigs, vapor, e-liquid, e-juice, vape, vaping devices) compared to women who smoke conventional cigarettes. Aim 2. To compare toxicant exposure and birth outcomes among infants born to pregnant women w...
What is the current status of trial NCT03480373?
This trial is currently completed. The enrollment target is 182 participants. The study started on 2018-06-18. Estimated completion is 2023-08-30.
What conditions does trial NCT03480373 study?
This clinical trial studies the following conditions: Cigarette Smoking-Related Carcinoma.
Who is sponsoring clinical trial NCT03480373?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03480373 being conducted?
This trial has 6 study locations across Colorado, Connecticut, Massachusetts, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cigarette Smoking-Related Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03480373's enrollment target sits among peer trials
182 10th of 21 higher than 11 of 21 other Cigarette Smoking-Related Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cigarette Smoking-Related Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking, IndigeQuit Trial
RECRUITING · NA
-
Carcinogen and Toxicant Exposure Among Young Adults Who Co-Use E-cigarettes and Cannabis (Co-Tox Study)
RECRUITING
-
Sensory Tests of Cigarettes for Identification of Flavors in Current Daily Smoking Adults
RECRUITING · Early Phase 1
-
Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
RECRUITING · Phase 4
-
Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers
RECRUITING · Phase 2
-
CONNECTing to LungCare
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03897998 · 182 participants · Phase 2
Neural Correlates of Hypoalgesia Driven by Observation
- NCT04300556 · 182 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- NCT04323735 · 182 participants · Phase 2
Intravesical Lactobacillus for Urinary Symptoms Among People With NLUTD Who Use Indwelling Catheters
- NCT05606731 · 182 participants · NA
Family Intervention to Prevent Childhood Obesity
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI